Pharmacogenomic modeling in pancreatic cancer-letter

Avan, A. and Avan, A. and Maftouh, M. and Mobarhan, M. G. and Gholamin, S. (2015) Pharmacogenomic modeling in pancreatic cancer-letter. Clinical Cancer Research, 21 (6). p. 1497.

[img] Text
1497.full.pdf

Download (161kB)
Item Type: Article
Additional Information: Cited By :1 Export Date: 16 February 2020 CODEN: CCREF Correspondence Address: Avan, A.; VU University Medical Center Amsterdam, Laboratory Medical Oncology, CCA 1.58, De Boelelaan 1117, Netherlands
Uncontrolled Keywords: CA 19-9 antigen capecitabine docetaxel erlotinib fluorouracil gemcitabine irinotecan oxaliplatin paclitaxel antineoplastic agent cancer prognosis cancer staging drug response human Letter overall survival pancreas adenocarcinoma pancreas cancer pancreatic cancer cell line pharmacogenomics priority journal progression free survival tumor localization animal biological model drug resistance female genetics male metabolism Pancreatic Neoplasms pharmacogenetics tumor embolism Animals Antineoplastic Agents Drug Resistance, Neoplasm Humans Models, Biological Neoplastic Cells, Circulating
Subjects: QZ pathology-neoplasms-Genetics
Divisions: Mashhad University of Medical Sciences
Depositing User: mr lib5 lib5
Date Deposited: 05 May 2020 07:43
Last Modified: 05 May 2020 07:43
URI: http://eprints.mums.ac.ir/id/eprint/18761

Actions (login required)

View Item View Item